For instance, in ovarian cancer, HK2 is highly expressed in cancer tissues compared with normal, benign, and borderline ovarian tumors (35), suggesting targeting HK2 is a promising approach for cancer treatment. Here, HK2 is linked to ovarian carcinoma.